Blood test may predict immunotherapy success in lung and Head/Neck cancers
NCT ID NCT05091190
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 34 times
Summary
This study looks at how well immunotherapy works in patients with advanced lung or head/neck cancer. Researchers will measure how fast the drug leaves the body and track tumor cells in the blood. The goal is to find better ways to predict which patients will benefit from treatment. About 75 adults will participate, providing blood samples before and during therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Croix Rousse Hospital
Lyon, France
-
Lyon Sud Hospital
Pierre-Bénite, France
Conditions
Explore the condition pages connected to this study.